Active substancePotassium chloride + Sodium acetate + Sodium chloridePotassium chloride + Sodium acetate + Sodium chloride
Similar drugsTo uncover
  • Acesol
    solution in / in 
    BIOSINTEZ, PAO     Russia
  • Acesol
    solution in / in 
  • Acesol
    solution d / infusion 
    KRASFARMA, JSC     Russia
  • Acesol
    solution d / infusion 
  • Acesol
    solution d / infusion 
    GROTEKS, LLC     Russia
  • Acesol
    solution d / infusion 
    RESTER, CJSC     Russia
  • Acesol
    solution d / infusion 
    GEMATEK, LLC     Russia
  • Acesol
    solution d / infusion 
    ESKOM NPK, OAO     Russia
  • Acesol
    solution d / infusion 
    DALHIMFARM, OJSC     Russia
  • Acesol
    solution d / infusion 
  • Chlossol
    solution in / in 
    BIOCHEMIST, OJSC     Russia
  • Chlossol
    solution in / in 
    GROTEKS, LLC     Russia
  • Chlossol
    solution in / in 
  • Dosage form: & nbspsolution for infusions
    Composition:

    Composition per one liter:

    Active substances:

    Sodium chloride - 5 g

    Sodium acetate trihydrate - 2 g

    Potassium chloride -1 g

    Excipients:

    Water for injection - up to 1 liter

    Ionic composition per 1 liter:

    Sodium-ion-100.3 mmol

    Chloride ion 99.0 mmol

    Acetate-14.7 mmol

    Potassium ion-13.4 mmol

    Theoretical osmolarity - 227 mOsm / l

    Description:

    Transparent colorless liquid.

    Pharmacotherapeutic group:Rehydrating agent
    ATX: & nbsp

    B.05.B.B.01   Electrolytes

    Pharmacodynamics:

    Combined saline solution for rehydration and detoxification. Has a hemodynamic effect, reducing hypovolemia, preventing blood thickening and the development of metabolic acidosis, improves capillary circulation, increases diuresis and exerts detoxification effect.

    Pharmacokinetics:It is excreted by the kidneys.
    Indications:

    Dehydration, intoxication on the background of dehydration (cholera, acute shigellosis, food toxicoinfection).

    Contraindications:

    Hyperkalemia, heart failure, alkalosis, the presence of contraindications to the introduction of large quantities of liquid into the body.

    Carefully:

    Use with caution in patients with impaired renal excretion.

    Pregnancy and lactation:

    The use of the drug during pregnancy is possible only if the intended benefit to the mother exceeds the potential risk to the fetus. It should refrain from breastfeeding during the period of use of the drug because of the lack of relevant clinical data.

    Dosing and Administration:

    The drug is used only for moderate and severe conditions when it is impossible to take solutions for oral rehydration.

    Intravenously (struino and drip), under the control of laboratory indicators. Within 1 hour, injections are introduced, then the jet infusion is replaced by a dropwise addition, for 24-48 hours at a rate of 40-120 cal / min. Before administration, the solution is heated to 36 - 38 ° C. The solution is administered in amounts necessary to restore the volume of fluid lost with feces, vomit, urine, sweat.

    The balance of the injected and lost liquid is determined every 6 hours.

    Side effects:

    Edema, tachycardia, hyperkalemia, chills.

    Overdose:No reports of overdose cases.
    Interaction:

    When combined with other drugs, it is necessary to visually control the pharmaceutical compatibility.

    Special instructions:

    Before administration, the solution is heated to 36 - 38 ° C. Therapy is carried out under the control of hematocrit and the concentration of blood electrolytes. With the development of hyperkalemia, the solution can be replaced with a solution of Disol until the electrolyte balance is normalized. In general, when dehydration shows the use of solutions for oral rehydration, and only if this method is not possible (for one reason or another), the drug Acesol is administered.

    Effect on the ability to drive transp. cf. and fur:

    It was not reported on the effect of the drug on psychophysiological reactions and the ability to control vehicles and mechanisms.

    Form release / dosage:

    Solution for infusion.

    Packaging:

    For 100, 200, 250, 400, 500 or 1000 ml in polypropylene bottles, sealed with welded polypropylene caps.

    One bottle together with instructions for use in a pack of cardboard.

    For hospitals

    From 1 to 40 vials of 100, 200, 250, 400, 500 or 1000 ml together with instructions for use in an amount equal to the number of vials in a corrugated box of cardboard.
    Storage conditions:

    Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.

    Shelf life:

    2 years. Do not use after the expiration date!

    Terms of leave from pharmacies:On prescription
    Registration number:LP-002712
    Date of registration:14.11.2014
    Expiration Date:14.11.2019
    The owner of the registration certificate:GROTEKS, LLC GROTEKS, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp03.10.2017
    Illustrated instructions
      Instructions
      Up